Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 7, 2016, Pages 1877-1882

  Hosoya, Hitomi ^a,b   Dobroff, Andrey S ^c,d   Driessen, Wouter H P ^e,o   Cristini, Vittorio ^e,f   Brinker, Lina M ^c,d   Staquicini, Fernanda I ^c,d   Cardó Vila, Marina ^c,d   D'Angelo, Sara ^c,g   Ferrara, Fortunato ^c,g   Proneth, Bettina ^e,p   Lin, Yu Shen ^h   Dunphy, Darren R ^i,j   Dogra, Prashant ^c,d   Melancon, Marites P ^e   Stafford, R Jason ^e   Miyazono, Kohei ^a   Gelovani, Juri G ^k   Kataoka, Kazunori ^a,l   Brinker, C Jeffrey ^c,i,j,m   Sidman, Richard L ⁿ   Arap, Wadih ^c,d   Pasqualini, Renata ^c,d   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g LOS ALAMOS NATIONAL LABORATORY   (United States)

^h Oncothyreon   (United States)

ⁱ UNIVERSITY OF NEW MEXICO   (United States)

^j SANDIA NATIONAL LABORATORIES   (United States)

^k Wayne State University   (United States)

^l UNIVERSITY OF TOKYO   (Japan)

^m MSC01 1070   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o F HOFFMANN LA ROCHE LTD   (Switzerland)

^p INSTITUTE OF EPIDEMIOLOGY   (Germany)

more..

Author keywords

Ligand receptor; Mathematical modeling; Nanoparticle; Phage display; Photothermal therapy

Indexed keywords

DOXORUBICIN; GADOLINIUM; GOLD NANOPARTICLE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; ANTINEOPLASTIC AGENT;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DENSITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; FLUORESCENCE IMAGING SYSTEM; HYDROGEL; HYDROGEN BOND; IN VITRO STUDY; LOW LEVEL LASER THERAPY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; MULTIMODAL IMAGING; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE TRANSITION; PRIORITY JOURNAL; PROSTATE CANCER; RAMAN SPECTROMETRY; RELAXATION TIME; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; DISEASE MODEL; FEMALE; INFRARED RADIATION; NUDE MOUSE; PROSTATIC NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; INFRARED RAYS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIMODAL IMAGING; NANOTECHNOLOGY; PROSTATIC NEOPLASMS; SURFACE PLASMON RESONANCE;

EID: 84959020202     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1525796113     Document Type: Article

References (36)

1. Nichols JW, Bae YH (2012) Odyssey of a cancer nanoparticle: From injection site to site of action. Nano Today 7(6): 606-618.
2. Kumari P, Ghosh B, Biswas S (2016) Nanocarriers for cancer-targeted drug delivery. J Drug Target 24(3): 179-191.
3. Liu J, Stace-Naughton A, Jiang X, Brinker CJ (2009) Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. J Am Chem Soc 131(4): 1354-1355.
4. Aslan B, Ozpolat B, Sood AK, Lopez-Berestein G (2013) Nanotechnology in cancer therapy. J Drug Target 21(10): 904-913.
5. Prabhu RH, Patravale VB, Joshi MD (2015) Polymeric nanoparticles for targeted treatment in oncology: Current insights. Int J Nanomedicine 10: 1001-1018.
6. Capolla S, et al. (2015) Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies. Int J Nanomedicine 10: 4099-4109.
7. Nicol JR, Dixon D, Coulter JA (2015) Gold nanoparticle surface functionalization: A necessary requirement in the development of novel nanotherapeutics. Nanomedicine (Lond) 10(8): 1315-1326.
8. Kang B, et al. (2015) Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona. Angew Chem Int Ed Engl 54(25): 7436-7440.
9. Müller LK, Landfester K (2015) Natural liposomes and synthetic polymeric structures for biomedical applications. Biochem Biophys Res Commun 468(3): 411-418.
10. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A (2012) Multifunctional nanoparticles: Cost versus benefit of adding targeting and imaging capabilities. Science 338(6109): 903-910.
11. Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine (Lond) 9(2): 194-201.
12. Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2(10): 750-763.
13. Shokeen M, et al. (2011) Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano 5(2): 738-747.
14. Galaway FA, Stockley PG (2013) MS2 viruslike particles: A robust, semisynthetic targeted drug delivery platform. Mol Pharm 10(1): 59-68.
15. Koppers-Lalic D, Hogenboom MM, Middeldorp JM, Pegtel DM (2013) Virus-modified exosomes for targeted RNA delivery: A new approach in nanomedicine. Adv Drug Deliv Rev 65(3): 348-356.
16. Smith MT, Hawes AK, Bundy BC (2013) Reengineering viruses and virus-like particles through chemical functionalization strategies. Curr Opin Biotechnol 24(4): 620-626.
17. Christianson DR, Ozawa MG, Pasqualini R, Arap W (2007) Techniques to decipher molecular diversity by phage display. Methods Mol Biol 357: 385-406.
18. Driessen WH, et al. (2010) On the synergistic effects of ligand-mediated and phageintrinsic properties during in vivo selection. Adv Genet 69: 115-133.
19. Souza GR, et al. (2008) Bottom-up assembly of hydrogels from bacteriophage and Au nanoparticles: The effect of cis- and trans-acting factors. PLoS One 3(5): E2242.
20. Souza GR, et al. (2006) Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA 103(5): 1215-1220.
21. Souza GR, et al. (2006) In vivo detection of gold-imidazole self-assembly complexes: NIR-SERS signal reporters. Anal Chem 78(17): 6232-6237.
22. KimMS, et al. (2014) Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Colloids Surf B Biointerfaces 116: 17-25.
23. Tarn D, et al. (2013) Mesoporous silica nanoparticle nanocarriers: Biofunctionality and biocompatibility. Acc Chem Res 46(3): 792-801.
24. Weisbecker CS, Merritt MV, Whitesides GM (1996) Molecular self-assembly of aliphatic thiols on gold colloids. Langmuir 12(16): 3763-3772.
25. Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev 91: 3-6.
26. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1): 6387-6392.
27. Mintz PJ, et al. (2009) An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment. Proc Natl Acad Sci USA 106(7): 2182-2187.
28. Hirsch LR, et al. (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100(23): 13549-13554.
29. Koay EJ, et al. (2014) Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 124(4): 1525-1536.
30. Pascal J, et al. (2013) Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response. ACS Nano 7(12): 11174-11182.
31. Pascal J, et al. (2013) Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements. Proc Natl Acad Sci USA 110(35): 14266-14271.
32. Sinek JP, et al. (2009) Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol 58(4-5): 485-510.
33. Ashley CE, et al. (2012) Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. ACS Nano 6(3): 2174-2188.
34. Epler K, et al. (2012) Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. Adv Healthc Mater 1(3): 348-353.
35. Ashley CE, et al. (2011) The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 10(5): 389-397.
36. Mandelin J, et al. (2015) Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors. Proc Natl Acad Sci USA 112(12): 3776-3781.